Tamoxifen and risk of endometrial cancer

Lancet. 2001 Jan 6;357(9249):66-7. doi: 10.1016/S0140-6736(05)71563-4.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents, Hormonal / adverse effects*
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Endometrial Neoplasms / chemically induced*
  • Female
  • Humans
  • Risk Factors
  • Tamoxifen / adverse effects*
  • Tamoxifen / therapeutic use

Substances

  • Antineoplastic Agents, Hormonal
  • Tamoxifen